The present invention provides monomers, analogs, and/or derivatives of bisphenols substituted with one or more fluoromethyl groups. These monomers, analogs, and/or derivatives can be used to form oligomers and/or polymers, which in turn can be used to make compounds with dielectric properties suitable for dielectric materials, including for example, use in energy dense capacitors. In a preferred embodiment, the compounds can comprise a polycarbonate of a homopolymer, copolymer, and/or terpolymer of a bisphenol with one or more fluoromethyl substitution groups. In an aspect of the invention the compounds chosen can be selected based on various desired characteristics, including, for example, their energy density, glass transition temperature, dielectric loss, and/or dipole density.

The present invention provides monomers, analogs, and/or derivatives of bisphenols substituted with one or more fluoromethyl groups. These monomers, analogs, and/or derivatives can be used to form oligomers and/or polymers, which in turn can be used to make compounds with dielectric properties suitable for dielectric materials, including for example, use in energy dense capacitors. In a preferred embodiment, the compounds can comprise a polycarbonate of a homopolymer, copolymer, and/or terpolymer of a bisphenol with one or more fluoromethyl substitution groups. In an aspect of the invention the compounds chosen can be selected based on various desired characteristics, including, for example, their energy density, glass transition temperature, dielectric loss, and/or dipole density.

The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbability and processibility are useful in a variety of medical applications, such as in medical devices and con-trolled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.

Crosslinkable polycarbonate resins having improved properties are disclosed. The crosslinkable polycarbonate resins are formed from a reaction of at least a benzophenone, a first dihydroxy chain extender, and a carbonate precursor, and may include a second dihydroxy chain extender as well.

Crosslinkable polycarbonate resins having improved properties are disclosed. The crosslinkable polycarbonate resins are formed from a reaction of at least a benzophenone, a first dihydroxy chain extender, and a carbonate precursor, and may include a second dihydroxy chain extender as well.

A polycarbonate composition includes: a continuous polycarbonate phase; discontinuous first domains distributed in the continuous phase, and comprising a core-shell silicone-(meth)acrylate impact modifier comprising a silicone elastomer core and a (meth)acrylate copolymer shell, wherein the first domains have an aspect ratio of at least 1.7, preferably at least 1.8; and discontinuous second domains distributed in the continuous phase, and comprising an alkenyl aromatic-olefin block copolymer impact modifier, wherein the second domains have an aspect ratio of at least 3, preferably at least 4, and a domain size of 6400 square nanometers or less, more preferably 5700 square nanometers or less. Optionally, the polycarbonate composition includes: a polycarbonate; a brominated polycarbonate different from the polycarbonate; a poly(carbonate-siloxane) comprising 30 to 70 weight percent of siloxane blocks; a core-shell silicone-(meth)acrylate impact modifier comprising a silicone elastomer core and an (meth)acrylate copolymer shell; and an alkenyl aromatic-olefin block copolymer impact modifier.

A polycarbonate composition includes: a continuous polycarbonate phase; discontinuous first domains distributed in the continuous phase, and comprising a core-shell silicone-(meth)acrylate impact modifier comprising a silicone elastomer core and a (meth)acrylate copolymer shell, wherein the first domains have an aspect ratio of at least 1.7, preferably at least 1.8; and discontinuous second domains distributed in the continuous phase, and comprising an alkenyl aromatic-olefin block copolymer impact modifier, wherein the second domains have an aspect ratio of at least 3, preferably at least 4, and a domain size of 6400 square nanometers or less, more preferably 5700 square nanometers or less. Optionally, the polycarbonate composition includes: a polycarbonate; a brominated polycarbonate different from the polycarbonate; a poly(carbonate-siloxane) comprising 30 to 70 weight percent of siloxane blocks; a core-shell silicone-(meth)acrylate impact modifier comprising a silicone elastomer core and an (meth)acrylate copolymer shell; and an alkenyl aromatic-olefin block copolymer impact modifier.

Provided is a polycarbonate-based resin composition, including: 50 mass % or more to 99 mass % or less of a polycarbonate-based resin (S) containing 0.1 mass % or more to 100 mass % or less of a polycarbonate-polyorganosiloxane copolymer (A), which contains a polycarbonate block (A-1) formed of a specific repeating unit and a polyorganosiloxane block (A-2) containing a specific repeating unit, and 0 mass % or more to 99.9 mass % or less of an aromatic polycarbonate-based resin (B) except the polycarbonate-polyorganosiloxane copolymer (A); 1 mass % or more to 50 mass % or less of a polyester-based resin (C); and 0.001 part by mass or more to 1 part by mass or less of an amide compound (D) with respect to 100 parts by mass of a total amount of the polycarbonate-based resin (S) and the polyester-based resin (C).

Provided is a polycarbonate-based resin composition, including: 50 mass % or more to 99 mass % or less of a polycarbonate-based resin (S) containing 0.1 mass % or more to 100 mass % or less of a polycarbonate-polyorganosiloxane copolymer (A), which contains a polycarbonate block (A-1) formed of a specific repeating unit and a polyorganosiloxane block (A-2) containing a specific repeating unit, and 0 mass % or more to 99.9 mass % or less of an aromatic polycarbonate-based resin (B) except the polycarbonate-polyorganosiloxane copolymer (A); 1 mass % or more to 50 mass % or less of a polyester-based resin (C); and 0.001 part by mass or more to 1 part by mass or less of an amide compound (D) with respect to 100 parts by mass of a total amount of the polycarbonate-based resin (S) and the polyester-based resin (C).

The present application provides polymer materials having the desired properties for implantation into a human or animal body, in particular, biocompatibility, biodegradability, radiopacity and mechanical properties. Methods of making such polymer materials, compositions or devices comprising such polymer materials, and uses of such polymer materials, compositions and devices are also disclosed.